|
Aggarwal, B.B., Eessalu, T.E. and Hass, P.E. (1985) Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature, 318, 665-667.
Ainbinder, E., Revach, M., Wolstein, O., Moshonov, S., Diamant, N. and Dikstein, R. (2002) Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol, 22, 6354-6362.
Balasenthil, S., Barnes, C.J., Rayala, S.K. and Kumar, R. (2004) Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett, 567, 243-247.
Beyaert, R. and Fiers, W. (1994) Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett, 340, 9-16.
Bezwoda, W.R. and Meyer, K. (1990) Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells. Cancer Res, 50, 5387-5391.
Bush, J.A., Cheung, K.J., Jr. and Li, G. (2001) Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res, 271, 305-314.
Byers, M., Kuiper, G.G., Gustafsson, J.A. and Park-Sarge, O.K. (1997) Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. Mol Endocrinol, 11, 172-182.
Campbell-Thompson, M., Lynch, I.J. and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res, 61, 632-640.
Coley, W.B. (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop, 3-11.
Cowley, S.M., Hoare, S., Mosselman, S. and Parker, M.G. (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem, 272, 19858-19862.
Delbes, G., Levacher, C., Pairault, C., Racine, C., Duquenne, C., Krust, A. and Habert, R. (2004) Estrogen receptor beta-mediated inhibition of male germ cell line development in mice by endogenous estrogens during perinatal life. Endocrinology, 145, 3395-3403.
Desagher, S. and Martinou, J.C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol, 10, 369-377.
Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J.C., Harigai, M., Samudio, I., Kladde, M.P., Vyhlidal, C. and Safe, S. (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J Biol Chem, 274, 32099-32107.
Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M. and Gustafsson, J.A. (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab, 82, 4258-4265.
Falcioni, R., Kennel, S.J., Giacomini, P., Zupi, G. and Sacchi, A. (1986) Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res, 46, 5772-5778.
Fiers, W. (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett, 285, 199-212.
Giguere, V., Tremblay, A. and Tremblay, G.B. (1998) Estrogen receptor beta: re-evaluation of estrogen and antiestrogen signaling. Steroids, 63, 335-339.
Grasso, P. (1981) Malnutrition, liver damage, and cancer. Nutr Cancer, 3, 103-108.
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.M., Argos, P. and Chambon, P. (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature, 320, 134-139.
Hall, J.M., Couse, J.F. and Korach, K.S. (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem, 276, 36869-36872.
Hayashi, S. and Yoshida, T. (2000) [Regulation of ER(estrogen receptor) gene expression in the genesis and development of breast cancer]. Nippon Rinsho, 58, 495-503.
Hui, R., Cornish, A.L., McClelland, R.A., Robertson, J.F., Blamey, R.W., Musgrove, E.A., Nicholson, R.I. and Sutherland, R.L. (1996) Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res, 2, 923-928.
Imamov, O., Morani, A., Shim, G.J., Omoto, Y., Thulin-Andersson, C., Warner, M. and Gustafsson, J.A. (2004) Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci U S A, 101, 9375-9380.
Ito, T., Tachibana, M., Yamamoto, S., Nakashima, J. and Murai, M. (2001) Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer. Eur Urol, 40, 557-563.
Jacobson, M.D., Weil, M. and Raff, M.C. (1997) Programmed cell death in animal development. Cell, 88, 347-354.
Kanzler, S. and Galle, P.R. (2000) Apoptosis and the liver. Semin Cancer Biol, 10, 173-184.
Katzenellenbogen, B.S., Montano, M.M., Ediger, T.R., Sun, J., Ekena, K., Lazennec, G., Martini, P.G., McInerney, E.M., Delage-Mourroux, R., Weis, K. and Katzenellenbogen, J.A. (2000) Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res, 55, 163-193; discussion 194-165.
Kim, H.S., Ingermann, A.R., Tsubaki, J., Twigg, S.M., Walker, G.E. and Oh, Y. (2004) Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res, 64, 2229-2237.
Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmeyer, D.D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science, 275, 1132-1136.
Konstantinopoulos, P.A., Kominea, A., Vandoros, G., Sykiotis, G.P., Andricopoulos, P., Varakis, I., Sotiropoulou-Bonikou, G. and Papavassiliou, A.G. (2003) Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer, 39, 1251-1258.
Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S. and Gustafsson, J.A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology, 138, 863-870.
Lamb, J., Ladha, M.H., McMahon, C., Sutherland, R.L. and Ewen, M.E. (2000) Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol Cell Biol, 20, 8667-8675.
Lee, J.S. and Thorgeirsson, S.S. (2002) Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology, 35, 1134-1143.
Li, J., Zheng, R. and Wang, Z. (2001) Mechanisms of the induction of apoptosis in human hepatoma cells by tumour necrosis factor-alpha. Cell Biol Int, 25, 1213-1219.
Li, P., Nijhawan, D. and Wang, X. (2004) Mitochondrial activation of apoptosis. Cell, 116, S57-59, 52 p following S59.
Locker, G.Y. (1998) Hormonal therapy of breast cancer. Cancer Treat Rev, 24, 221-240.
Lockshin, R.A. and Williams, C.M. (1965) Programmed Cell Death--I. Cytology of Degeneration in the Intersegmental Muscles of the Pernyi Silkmoth. J Insect Physiol, 11, 123-133.
Lottich, S.C., Johnston, W.W., Szpak, C.A., Delong, E.R., Thor, A. and Schlom, J. (1985) Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions. Breast Cancer Res Treat, 6, 49-56.
Martin, J.B. (1982) Huntington's disease: genetically programmed cell death in the human central nervous system. Nature, 299, 205-206.
Moggs, J.G. and Orphanides, G. (2001) Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep, 2, 775-781.
Moon, W.S., Chang, K. and Tarnawski, A.S. (2004) Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Hum Pathol, 35, 424-429.
Nagasue, N., Kohno, H., Chang, Y.C., Yamanoi, A., Nakamura, T., Yukaya, H. and Hayashi, T. (1990) Clinicopathologic comparisons between estrogen receptor-positive and -negative hepatocellular carcinomas. Ann Surg, 212, 150-154.
Nedwin, G.E., Naylor, S.L., Sakaguchi, A.Y., Smith, D., Jarrett-Nedwin, J., Pennica, D., Goeddel, D.V. and Gray, P.W. (1985) Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res, 13, 6361-6373.
Nicholson, D.W. and Thornberry, N.A. (1997) Caspases: killer proteases. Trends Biochem Sci, 22, 299-306.
Olefsky, J.M. (2001) Nuclear receptor minireview series. J Biol Chem, 276, 36863-36864.
Osborne, C.K., Zhao, H. and Fuqua, S.A. (2000) Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol, 18, 3172-3186.
Paech, K., Webb, P., Kuiper, G.G., Nilsson, S., Gustafsson, J., Kushner, P.J. and Scanlan, T.S. (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science, 277, 1508-1510.
Palmieri, C., Cheng, G.J., Saji, S., Zelada-Hedman, M., Warri, A., Weihua, Z., Van Noorden, S., Wahlstrom, T., Coombes, R.C., Warner, M. and Gustafsson, J.A. (2002) Estrogen receptor beta in breast cancer. Endocr Relat Cancer, 9, 1-13.
Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G.R., Firestone, G.L. and Leitman, D.C. (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res, 64, 423-428.
Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L. and Kriegler, M. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell, 63, 251-258.
Pettersson, K., Grandien, K., Kuiper, G.G. and Gustafsson, J.A. (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol, 11, 1486-1496.
Pisani, P., Parkin, D.M., Bray, F. and Ferlay, J. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 83, 18-29.
Ren, Z., Yang, B. and Ye, S. (1997) [Estrogen receptor expression and its relationship with biologic feature in hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi, 19, 10-13.
Saunders, P.T. (1998) Oestrogen receptor beta (ER beta). Rev Reprod, 3, 164-171.
Shima, Y., Nakao, K., Nakashima, T., Kawakami, A., Nakata, K., Hamasaki, K., Kato, Y., Eguchi, K. and Ishii, N. (1999) Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells. Hepatology, 30, 1215-1222.
Signoretti, S. and Loda, M. (2001) Estrogen receptor beta in prostate cancer: brake pedal or accelerator? Am J Pathol, 159, 13-16.
Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, R., Dower, S.K., Cosman, D. and Goodwin, R.G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019-1023.
Spyridopoulos, I., Sullivan, A.B., Kearney, M., Isner, J.M. and Losordo, D.W. (1997) Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation, 95, 1505-1514.
Struse, K., Audretsch, W., Rezai, M., Pott, G. and Bojar, H. (2000) The Estrogen Receptor Paradox in Breast Cancer: Association of High Receptor Concentrations with Reduced Overall Survival. Breast J, 6, 115-125.
Takemura, H., Kwan, C.Y. and Ohshika, H. (1995) Calcium antagonistic actions of tetrandrine depend on cell types. Res Commun Mol Pathol Pharmacol, 90, 59-68.
Tremblay, G.B., Tremblay, A., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Labrie, F. and Giguere, V. (1997) Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol, 11, 353-365.
Vater, C.A., Bartle, L.M., Dionne, C.A., Littlewood, T.D. and Goldmacher, V.S. (1996) Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts. Oncogene, 13, 739-748.
Vilcek, J. and Lee, T.H. (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem, 266, 7313-7316.
Villa, E., Camellini, L., Dugani, A., Zucchi, F., Grottola, A., Merighi, A., Buttafoco, P., Losi, L. and Manenti, F. (1995) Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma. Cancer Res, 55, 498-500.
Villa, E., Colantoni, A., Camma, C., Grottola, A., Buttafoco, P., Gelmini, R., Ferretti, I. and Manenti, F. (2003) Estrogen receptor classification for hepatocellular carcinoma: comparison with clinical staging systems. J Clin Oncol, 21, 441-446.
Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P. and Wang, X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-1132.
Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. and Horvitz, H.R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell, 75, 641-652.
Zimmermann, K.C., Bonzon, C. and Green, D.R. (2001) The machinery of programmed cell death. Pharmacol Ther, 92, 57-70.
|